FDA Grants Orphan Drug Status to ProMetic’s Plasminogen Drug
ProMetic Life Sciences Inc. (TSX:PLI) announced that the United States FDA has given an orphan drug designation to its plasminogen drug. The drug is used to treat type I plasminogen deficiency.
ProMetic Life Sciences Inc. (TSX:PLI) announced that the United States FDA has given an orphan drug designation to its plasminogen drug. The drug is used to treat type I plasminogen deficiency.
As quoted in the press release:
Orphan Drug Designation is granted to novel drugs or biologics that treat a rare disease or condition affecting fewer than 200,000 patients in the U.S. The designation provides the drug developer with a seven year period of U.S. marketing exclusivity upon marketing approval for the designated indication, as well as with tax credits for clinical research costs, the ability to apply for annual grant funding, clinical research trial design assistance and the waiver of prescription drug user fees.
Click here to read the full ProMetic Life Sciences Inc. (TSX:PLI) press release.
Â
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1774.96 | +1.14 | |
Silver | 19.90 | +0.01 | |
Copper | 3.55 | +0.07 | |
Palladium | 2124.59 | +12.40 | |
Platinum | 936.51 | +2.50 | |
Oil | 88.53 | -0.01 | |
Heating Oil | 3.20 | -0.13 | |
Natural Gas | 8.01 | -0.12 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured {{ post.primary_section_name }} Stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â